ProShares UltraShort Nasdaq Biotechnology -2x Shares Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 28.75 K | $272.57 K | 20.14% | 13.68% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.06 K | $10.09 K | -79.07% | 0.51% |
| MORGAN STANLEY | 02/13/2026 | 1 | $15 | 100.00% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 1 | $9 | 0.00% | 0.00% |
| CSENGE ADVISORY GROUP | 02/06/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ProShares UltraShort Nasdaq Biotechnology -2x Shares institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of ProShares UltraShort Nasdaq Biotechnology -2x Shares. The most heavily invested institutionals were:
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 28,752
Tower Research Capital LLC (TRC): 1,064
MORGAN STANLEY: 1
14.19% of ProShares UltraShort Nasdaq Biotechnology -2x Shares stock is owned by institutional investors.
Institutional investors have bought a total of 29.82 K shares in the last 24 months. This purchase volume represents approximately $261.79 K in transactions.